Description
PT-141
PT-141 is the development code commonly associated with bremelanotide, a cyclic melanocortin receptor agonist peptide.
Key Features
- Cataloged under the verified name PT-141
- Assigned catalog SKU ORI-PT141-001
- Public reference formula and molecular weight are separated from supplier specifications
- Research evidence is distinguished from merchandise documentation
- Product-specific scientific context presented without unsupported merchandise claims
Product Identity
Scientific reference sources describe PT-141 as the development code commonly associated with bremelanotide, a cyclic melanocortin receptor agonist peptide. This compound-level identification provides background for catalog review. It does not confirm the salt, counterion, hydration state, formulation, concentration, or contents of a supplied vial.
The current merchandise record confirms the name PT-141 and SKU ORI-PT141-001. Public reference information is presented separately from merchandise specifications.
Research Context
Bremelanotide has pharmacologic and human clinical evidence and is the active moiety in a regulated prescription product. PT-141 is also used as a research name. Approved labeling for a specific drug product does not establish that this catalog item has the same formulation, quality, classification, or intended use.
Specifications
| Product Name | PT-141 |
|---|---|
| SKU | ORI-PT141-001 |
| Public Reference Molecular Formula | C50H68N14O10 |
| Public Reference Molecular Weight | 1025.2 g/mol |
Reference data note: Public molecular data describes the named compound, not the unverified contents or specifications of this catalog item. Variant, salt, conjugate, and hydration differences can change molecular values.
Product Summary
- Product: PT-141
What is PT-141?
PT-141 is the development code commonly associated with bremelanotide, a cyclic melanocortin receptor agonist peptide. This answer describes the named scientific entity and does not verify the composition of SKU ORI-PT141-001.
What research has examined PT-141?
Bremelanotide has pharmacologic and human clinical evidence and is the active moiety in a regulated prescription product. PT-141 is also used as a research name. Approved labeling for a specific drug product does not establish that this catalog item has the same formulation, quality, classification, or intended use.
Are the molecular values product specifications?
No. Public reference values describe a named chemical entity. Supplier documentation and analytical testing are required to establish the identity and specifications of the actual catalog material.